Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.
about
Plague Vaccine Development: Current Research and Future TrendsOptimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity.B cells and antibodies in the defense against Mycobacterium tuberculosis infectionYopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infectionAntigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform.Adenovirus: the first effective in vivo gene delivery vectorDeveloping live vaccines against plague.Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.Progress on plague vaccine development.Adenovirus-vectored drug-vaccine duo as a potential driver for conferring mass protection against infectious diseases.Prospects for oral replicating adenovirus-vectored vaccines.Plague Vaccines: Status and Future.The effect of fiber truncations on the stability of adenovirus type 5.Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.
P2860
Q28066875-53AE2DDA-A4BF-4C92-BBFE-C06D56CD9024Q35666180-59A28E62-905F-403F-824E-6CA24043FA92Q36238031-38079A11-0D11-43AF-B49C-F79238C3D495Q36283058-49CB01A2-9B2E-40A0-9BC7-581167A74C54Q36330007-70F9FA15-B57C-453E-9986-3A8F1637A841Q37508260-A34C0B68-CA24-4ADF-84DC-2FC610E24DECQ37599376-8125A571-7C77-4E1C-96DE-A47079444DCBQ37806749-84E38D96-554C-4F60-A01E-B0254DC69A3BQ37889155-D6739C0D-7400-4D3A-8384-183E245997DEQ37951524-3CB01A8C-5C3B-41EE-AD04-2E92ED579B02Q38109356-E3E16ABD-E00C-49A4-A5F2-C3F7A00DABF2Q38813137-73C0A9E2-9B5B-44EE-8DCF-5974B752F15BQ42209051-52C7A3DA-CC8F-4D4B-8801-56A4F760993AQ55361721-FE3182DE-6A57-4AE7-AAC4-43E37C5AC9D6
P2860
Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Protective immunity against a ...... orated into adenovirus capsid.
@ast
Protective immunity against a ...... orated into adenovirus capsid.
@en
Protective immunity against a ...... orated into adenovirus capsid.
@nl
type
label
Protective immunity against a ...... orated into adenovirus capsid.
@ast
Protective immunity against a ...... orated into adenovirus capsid.
@en
Protective immunity against a ...... orated into adenovirus capsid.
@nl
prefLabel
Protective immunity against a ...... orated into adenovirus capsid.
@ast
Protective immunity against a ...... orated into adenovirus capsid.
@en
Protective immunity against a ...... orated into adenovirus capsid.
@nl
P2093
P2860
P356
P1433
P1476
Protective immunity against a ...... orated into adenovirus capsid.
@en
P2093
Carolina Sofer-Podesta
David Perlin
Julie L Boyer
Maria J Chiuchiolo
Neil R Hackett
Ronald G Crystal
Svetlana Senina
P2860
P304
P356
10.1089/HUM.2009.148
P577
2010-07-01T00:00:00Z